We work with leading diabetes professionals to ensure that our products deliver exceptional results and meet the highest standards of efficacy and safety. Orville Kolterman, M.D. worked with our co-founders, our team of scientists, and our nutritionists to develop Pendulum Glucose Control.
Who is Orville Kolterman, M.D.?
Orville Kolterman, M.D. is our Chief Medical Officer (CMO) and the leader of our medical research team. Dr. Kolterman is well-respected as a diabetes expert. This is due to his contributions in drug development and to the Diabetes community as a whole.
Why did you choose to work with him?
We’re committed to doing good clinical and research science, and working with a leading professional like Dr. Kolterman reflects that commitment. Not only is he well-respected, he also brings a great deal of experience to our team. You can read more details about Dr. Kolterman below.
- Dr. Kolterman was the Chief Medical Officer at Amylin Pharmaceuticals. While there, he brought four diabetes drugs from early stage development through trials and to market.
- Dr. Kolterman served as the President of the California Affiliate of the American Diabetes Association. He's also an Adjunct Professor of Medicine at the University of California, San Diego.
- Dr. Kolterman received his MD from Stanford University School of Medicine. He performed his residency in Internal Medicine at the University of Chicago. Later, he returned to Stanford for his endocrinology training.